Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.

Kastrinos F, Steyerberg EW, Balmaña J, Mercado R, Gallinger S, Haile R, Casey G, Hopper JL, LeMarchand L, Lindor NM, Newcomb PA, Thibodeau SN, Syngal S; Colon Cancer Family Registry.

Gut. 2013 Feb;62(2):272-9. doi: 10.1136/gutjnl-2011-301265. Epub 2012 Feb 16.

2.

Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.

Vasen HF, Hendriks Y, de Jong AE, van Puijenbroek M, Tops C, Bröcker-Vriends AH, Wijnen JT, Morreau H.

Dis Markers. 2004;20(4-5):207-13. Review.

3.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

4.

A comparative study of quantitative immunohistochemistry and quantum dot immunohistochemistry for mutation carrier identification in Lynch syndrome.

Barrow E, Evans DG, McMahon R, Hill J, Byers R.

J Clin Pathol. 2011 Mar;64(3):208-14. doi: 10.1136/jcp.2010.084418. Epub 2010 Dec 22. Review.

PMID:
21177748
5.

Clinical significance of microsatellite instability in colorectal cancer.

Kloor M, Staffa L, Ahadova A, von Knebel Doeberitz M.

Langenbecks Arch Surg. 2014 Jan;399(1):23-31. doi: 10.1007/s00423-013-1112-3. Epub 2013 Sep 19. Review.

PMID:
24048684
6.

Lynch Syndrome.

Kohlmann W, Gruber SB.

In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2017.
2004 Feb 5 [updated 2014 May 22].

7.

[Lynch syndrome in the hands of pathologists].

Daum O, Beneš Z, Hadravský L, Stehlík J, Cerná K, Dušek M, Kokošková B, Michal M.

Cesk Patol. 2014 Jan;50(1):18-24. Review. Czech.

PMID:
24624982
8.

Lynch syndrome in the 21st century: clinical perspectives.

Tiwari AK, Roy HK, Lynch HT.

QJM. 2016 Mar;109(3):151-8. doi: 10.1093/qjmed/hcv137. Epub 2015 Jul 29. Review.

PMID:
26224055
9.

Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer.

Yamamoto H, Adachi Y, Taniguchi H, Kunimoto H, Nosho K, Suzuki H, Shinomura Y.

World J Gastroenterol. 2012 Jun 14;18(22):2745-55. doi: 10.3748/wjg.v18.i22.2745. Review.

10.

Criteria and prediction models for mismatch repair gene mutations: a review.

Win AK, Macinnis RJ, Dowty JG, Jenkins MA.

J Med Genet. 2013 Dec;50(12):785-93. doi: 10.1136/jmedgenet-2013-101803. Epub 2013 Aug 16. Review.

PMID:
23956446
11.

Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome.

Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN.

Fam Cancer. 2005;4(3):255-65. Review.

PMID:
16136387
12.

Evolving approach and clinical significance of detecting DNA mismatch repair deficiency in colorectal carcinoma.

Shia J.

Semin Diagn Pathol. 2015 Sep;32(5):352-61. doi: 10.1053/j.semdp.2015.02.018. Epub 2015 Feb 4. Review.

13.

Review: Clinical aspects of hereditary DNA Mismatch repair gene mutations.

Sijmons RH, Hofstra RM.

DNA Repair (Amst). 2016 Feb;38:155-62. doi: 10.1016/j.dnarep.2015.11.018. Epub 2015 Dec 11. Review.

PMID:
26746812
14.

Risk of breast cancer in Lynch syndrome: a systematic review.

Win AK, Lindor NM, Jenkins MA.

Breast Cancer Res. 2013 Mar 19;15(2):R27. doi: 10.1186/bcr3405. Review.

15.

Approach to Lynch Syndrome for the Gastroenterologist.

Bui QM, Lin D, Ho W.

Dig Dis Sci. 2017 Feb;62(2):299-304. doi: 10.1007/s10620-016-4346-4. Epub 2016 Dec 18. Review.

PMID:
27990589
16.

Microsatellite Instability as a Biomarker for PD-1 Blockade.

Dudley JC, Lin MT, Le DT, Eshleman JR.

Clin Cancer Res. 2016 Feb 15;22(4):813-20. doi: 10.1158/1078-0432.CCR-15-1678. Review.

17.

Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome.

Win AK, Clendenning M, Crawford W, Rosty C, Preston SG, Southey MC, Parry S, Giles GG, Macrae FA, Winship IM, Baron JA, Hopper JL, Jenkins MA, Buchanan DD.

Genes Cancer. 2015 Nov;6(11-12):445-51. Review.

18.

Strategies for clinical implementation of screening for hereditary cancer syndromes.

Heald B, Marquard J, Funchain P.

Semin Oncol. 2016 Oct;43(5):609-614. doi: 10.1053/j.seminoncol.2016.08.008. Epub 2016 Sep 21. Review.

PMID:
27899194
19.

Prediction models in Lynch syndrome.

Kastrinos F, Balmaña J, Syngal S.

Fam Cancer. 2013 Jun;12(2):217-28. doi: 10.1007/s10689-013-9632-0. Review.

20.

A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome.

Boonstra PS, Gruber SB, Raymond VM, Huang SC, Timshel S, Nilbert M, Mukherjee B.

Genet Epidemiol. 2010 Nov;34(7):756-68. doi: 10.1002/gepi.20534. Review.

Supplemental Content

Support Center